N/C Interactions Are Dispensable for Normal In Vivo Functioning of the Androgen Receptor in Male Mice.


Journal

Endocrinology
ISSN: 1945-7170
Titre abrégé: Endocrinology
Pays: United States
ID NLM: 0375040

Informations de publication

Date de publication:
01 09 2022
Historique:
received: 16 05 2022
pubmed: 1 8 2022
medline: 9 8 2022
entrez: 31 7 2022
Statut: ppublish

Résumé

The androgen receptor (AR) plays a central role in the development and maintenance of the male phenotype. The binding of androgens to the receptor induces interactions between the carboxyterminal ligand-binding domain and the highly conserved 23FQNLF27 motif in the aminoterminal domain. The role of these so-called N/C interactions in AR functioning is debated. In vitro assays show that mutating the AR in the 23FQNLF27 motif (called ARNoC) attenuates the AR transactivation of reporter genes, has no effect on ligand binding, but does affect protein-protein interactions with several AR coregulators. To test the in vivo relevance of the N/C interaction, we analyzed the consequences of the genomic introduction of the ARNoC mutation in mice. Surprisingly, the ARNoC/Y mice show a normal male development, with unaffected male anogenital distance and normal accessory sex glands, male circulating androgen levels, body composition, and fertility. The responsiveness of androgen target genes in kidney, prostate, and testes was also unaffected. We thus conclude that the N/C interactions in the AR are not essential for the development of a male phenotype under normal physiological conditions.

Identifiants

pubmed: 35908178
pii: 6652495
doi: 10.1210/endocr/bqac104
pmc: PMC9756762
pii:
doi:

Substances chimiques

AR protein, mouse 0
Androgens 0
Ligands 0
Receptors, Androgen 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NICHD NIH HHS
ID : P50 HD028934
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

EMBO J. 2014 Feb 18;33(4):312-26
pubmed: 24451200
Nature. 1997 Jun 12;387(6634):733-6
pubmed: 9192902
Mol Endocrinol. 2005 Feb;19(2):350-61
pubmed: 15514032
Mol Endocrinol. 2006 Apr;20(4):776-85
pubmed: 16373397
Mol Cell Biol. 2003 Mar;23(6):2135-50
pubmed: 12612084
Mol Cell Proteomics. 2017 Aug;16(8):1462-1474
pubmed: 28611094
J Biol Chem. 2013 Feb 22;288(8):5463-74
pubmed: 23281476
Asian J Androl. 2016 Sep-Oct;18(5):687-94
pubmed: 27212126
J Clin Endocrinol Metab. 2003 Sep;88(9):4043-54
pubmed: 12970260
Trends Pharmacol Sci. 2005 May;26(5):225-8
pubmed: 15860367
Sci Rep. 2016 Oct 17;6:35539
pubmed: 27748448
Endocr Relat Cancer. 2004 Mar;11(1):117-30
pubmed: 15027889
J Biol Chem. 2001 Mar 2;276(9):6695-702
pubmed: 11078741
Methods Mol Biol. 2011;776:81-93
pubmed: 21796522
J Biol Chem. 2011 Aug 26;286(34):29951-63
pubmed: 21730049
J Biol Chem. 2003 Mar 7;278(10):8212-8
pubmed: 12509416
Mol Endocrinol. 2010 May;24(5):898-913
pubmed: 20304998
J Cell Sci. 2012 Apr 15;125(Pt 8):1970-9
pubmed: 22328501
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4758-63
pubmed: 15037741
Methods Mol Biol. 2011;776:113-29
pubmed: 21796524
BMC Biochem. 2013 Apr 08;14:10
pubmed: 23566155
Eur J Biochem. 2002 Dec;269(23):5780-91
pubmed: 12444966
Mol Cell. 2020 Sep 3;79(5):812-823.e4
pubmed: 32668201
J Biol Chem. 2002 Mar 22;277(12):10226-35
pubmed: 11779876
Anal Bioanal Chem. 2013 Oct;405(26):8569-77
pubmed: 23892882
Endocrinology. 1973 Apr;92(4):1223-8
pubmed: 4686318
Endocr Relat Cancer. 2006 Dec;13(4):979-94
pubmed: 17158750
Bone. 2016 Dec;93:33-42
pubmed: 27622887
J Cell Biol. 2007 Apr 9;177(1):63-72
pubmed: 17420290
J Immunol. 2014 Sep 15;193(6):3146-54
pubmed: 25122923
Arch Toxicol. 2019 Feb;93(2):253-272
pubmed: 30430187
PLoS One. 2012;7(11):e49026
pubmed: 23145053
EMBO Rep. 2021 Dec 6;22(12):e52764
pubmed: 34661369
Mol Cell Endocrinol. 2012 Jan 30;348(2):403-10
pubmed: 21664945
Nucl Recept Signal. 2008 Jun 27;6:e008
pubmed: 18612376
Mol Genet Metab. 2002 Apr;75(4):293-8
pubmed: 12051960
J Biol Chem. 2000 Aug 25;275(34):26164-71
pubmed: 10840043
Mol Cell Endocrinol. 2014 Jan 25;382(1):97-106
pubmed: 24055275
FASEB J. 2014 Jul;28(7):2979-94
pubmed: 24671706
Endocrinology. 2000 May;141(5):1642-7
pubmed: 10803572
Mol Cell Biol. 2007 Mar;27(5):1823-43
pubmed: 17189428
Mol Endocrinol. 2004 Sep;18(9):2132-50
pubmed: 15178743
Mol Cell Biol. 1999 Sep;19(9):6085-97
pubmed: 10454556
Nat Methods. 2011 Jan;8(1):70-3
pubmed: 21131968
Mol Cell. 2004 Nov 5;16(3):425-38
pubmed: 15525515

Auteurs

Sarah El Kharraz (S)

Department of Cellular and Molecular Medicine, Molecular Endocrinology Laboratory, KU Leuven, Leuven, 3000, Belgium.

Vanessa Dubois (V)

Department of Chronic Diseases and Metabolism, Clinical and Experimental Endocrinology, KU Leuven, Leuven, 3000, Belgium.
Department of Basic and Applied Medical Sciences, Basic and Translational Endocrinology, Ghent University, Ghent, 9000, Belgium.

Kaisa-Mari Launonen (KM)

Institute of Biomedicine, University of Eastern Finland, Kuopio, 70210, Finland.

Laura Helminen (L)

Institute of Biomedicine, University of Eastern Finland, Kuopio, 70210, Finland.

Jorma J Palvimo (JJ)

Institute of Biomedicine, University of Eastern Finland, Kuopio, 70210, Finland.

Claude Libert (C)

VIB Center for Inflammation Research, VIB, Ghent, 9052, Belgium.
Department for Biomedical Molecular Biology, Ghent University, Ghent, 9052, Belgium.

Elien Smeets (E)

Department of Cellular and Molecular Medicine, Molecular Endocrinology Laboratory, KU Leuven, Leuven, 3000, Belgium.

Lisa Moris (L)

Department of Cellular and Molecular Medicine, Molecular Endocrinology Laboratory, KU Leuven, Leuven, 3000, Belgium.

Roy Eerlings (R)

Department of Cellular and Molecular Medicine, Molecular Endocrinology Laboratory, KU Leuven, Leuven, 3000, Belgium.

Dirk Vanderschueren (D)

Department of Chronic Diseases and Metabolism, Clinical and Experimental Endocrinology, KU Leuven, Leuven, 3000, Belgium.

Christine Helsen (C)

Department of Cellular and Molecular Medicine, Molecular Endocrinology Laboratory, KU Leuven, Leuven, 3000, Belgium.

Frank Claessens (F)

Department of Cellular and Molecular Medicine, Molecular Endocrinology Laboratory, KU Leuven, Leuven, 3000, Belgium.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH